FDA Grants Tentative Approval of a Three-Component AIDS Drug In
FDA Grants Tentative Approval of a Three-Component AIDS Drug In Association with the President s Emergency Plan for AIDS Relief
The first tentative approval for a three-ingredient fixed dose tablet for use as a stand-alone antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.